The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Open accessAbstract
We have shown that nanoparticles (NPs) conjugated to trans-activating transcriptor (TAT) peptide bypass the efflux action of P-glycoprotein and increases the transport of the encapsulated ritonavir, a protease inhibitor (PI), across the blood-brain-barrier (BBB) to the central nervous system (CNS). A steady increase in the drug parenchyma/capillary ratio with time without disrupting the BBB integrity suggests that TAT-conjugated NPs are first immobilized in the brain vasculature prior to their transport into parenchyma. Localization of NPs in the brain parenchyma was further confirmed with histological analysis of the brain sections. The brain drug level with conjugated NPs was 800-fold higher than that with drug in solution at two weeks. Drug clearance was seen within four weeks. In conclusion, TAT-conjugated NPs enhance the CNS bioavailability of the encapsulated PI and maintained therapeutic drug level in the brain for a sustained period that could be effective in reducing the viral load in the CNS which acts as a reservoir for replicating HIV-1 virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Self-citationTat peptide-mediated intracellular delivery of pharmaceutical nanocarriers
Torchilin, V. P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.008 · Cited by 449
Choo, E. F., Leake, B., Wandel, C., Imamura, H., Wood, A. J. J., Wilkinson, G. R., & Kim, R. B. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15144-6 · Cited by 395
Neurologic complications of HIV disease and their treatment.
Letendre, S. L., Ellis, R. J., Everall, I., Ances, B., Bharti, A., & McCutchan, J. A. (2006) · PubMed · Cited by 349
Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrier
Wang, Q., Rager, J. D., Weinstein, K., Kardos, P. S., Dobson, G. L., Li, J., & Hidalgo, I. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.007 · Cited by 348
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Self-citationSahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Self-citationPanyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Self-citationCationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
Lu, W., Zhang, Y., Tan, Y.-Z., Hu, K.-L., Jiang, X.-G., & Fu, S.-K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.027 · Cited by 311
Schrager, L. K. (1998) · JAMA · doi:10.1001/jama.280.1.67 · Cited by 301
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283
Silhol, M., Tyagi, M., Giacca, M., Lebleu, B., & Vivès, E. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02671.x · Cited by 268
Tat Peptide Directs Enhanced Clearance and Hepatic Permeability of Magnetic Nanoparticles
Wunderbaldinger, P., Josephson, L., & Weissleder, R. (2002) · Bioconjugate Chemistry · doi:10.1021/bc015563u · Cited by 266
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Franke, H., Galla, H.-J., & Beuckmann, C. T. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00020-9 · Cited by 227
Rapid and effective labeling of brain tissue using TAT-conjugated CdS∶Mn/ZnS quantum dots
Santra, S., Yang, H., Stanley, J. T., Holloway, P. H., Moudgil, B. M., Walter, G., & Mericle, R. A. (2005) · Chemical Communications · doi:10.1039/b503234b · Cited by 215
Bazile, D. V., Ropert, C., Huve, P., Verrecchia, T., Mariard, M., Frydman, A., Veillard, M., & Spenlehauer, G. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90142-b · Cited by 200
A Review of Nanocarrier-Based CNS Delivery Systems
Tiwari, S., & Amiji, M. (2006) · Current Drug Delivery · doi:10.2174/156720106776359230 · Cited by 200
Banks, W. A., Freed, E. O., Wolf, K. M., Robinson, S. M., Franko, M. W., & Kumar, V. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4681-4691.2001 · Cited by 138
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency
Liang, J. F., & Yang, V. C.-M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.142 · Cited by 124
Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux
Chavanpatil, M. D., Khdair, A., Gérard, B., Bachmeier, C. J., Miller, D. W., Shekhar, M. P. V., & Panyam, J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070024d · Cited by 117
Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers
Koch, A., Reynolds, F., Merkle, H. P., Weissleder, R., & Josephson, L. (2005) · ChemBioChem · doi:10.1002/cbic.200400174 · Cited by 99
Notermans, D. W., Goudsmit, J., Danner, S. A., de Wolf, F., Perelson, A. S., & Mittler, J. E. (1998) · AIDS · doi:10.1097/00002030-199812000-00010 · Cited by 95
Cerebrospinal Fluid HIV RNA and Drug Levels With Combination Ritonavir and Saquinavir
Kravcik, S., Gallicano, K., Roth, V. R., Cassol, S. A., Hawley‐Foss, N., Badley, A. D., & Cameron, D. W. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199908150-00003 · Cited by 93
Pharmacokinetics and Delivery of Tat and Tat-Protein Conjugates to Tissues in Vivo
Lee, H. J., & Pardridge, W. M. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0155061 · Cited by 91
HIV‐Tat protein induces P‐glycoprotein expression in brain microvascular endothelial cells
Hayashi, K., Pu, H., Tian, J., Andras, I. E., Lee, Y. W., Hennig, B., & Toborek, M. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03114.x · Cited by 78
HIV-1 protease inhibitors and the MDR1 multidrug transporter.
Lee, C. G. L., & Gottesman, M. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2575 · Cited by 71
Samii, A., Bickel, U., Stroth, U., & Pardridge, W. M. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.1.e124 · Cited by 67
Understanding and circumventing the blood-brain barrier
Begley, D. J. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00226.x · Cited by 60
Kaddoumi, A., Choi, S., Kinman, L., Whittington, D., Tsai, C., Ho, R. J. Y., Anderson, B. D., & Unadkat, J. D. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016220 · Cited by 58
Tripathi, S., Chaubey, B., Ganguly, S., Harris, D., Casale, R. A., & Pandey, V. N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki743 · Cited by 53
Perloff, M. D., Moltke, L. L., Fahey, J. M., & Greenblatt, D. J. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0006 · Cited by 47
Evaluation of a brain-targeting zidovudine chemical delivery system in dogs
Brewster, M. E., Anderson, W. R., Webb, A. I., Pablo, L., Meinsma, D., Moreno, D., Derendorf, H., Bodor, N. S., & Pop, E. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.122 · Cited by 40
Zhang, X., Wan, L., Pooyan, S., Su, Y., Gardner, C. R., Leibowitz, M. J., Stein, S., & Sinko, P. J. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034014y · Cited by 35
Torrence, P. F., Kinjo, J., Khamnei, S., & Greig, N. H. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00057a002 · Cited by 29
Trans-Activating Transcriptional Activator (TAT) Peptide-Mediated Brain Drug Delivery
Rao, K. S., & Labhasetwar, V. (2006) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2006.036 · Cited by 17
Self-citationDizhe, E. B., Ignatovich, I. A., Burov, S. V., Pohvoscheva, A. V., Akifiev, B. N., Efremov, A. M., Ap, P., & Orlov, S. (2006) · Biochemistry (Moscow) · doi:10.1134/s0006297906120108 · Cited by 16
Cited by
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 565
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Yuan, H., Fales, A. M., & Vo-Dinh, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304180y · Cited by 523
Metadata
- Authors
- Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 29
- Issue
- 33
- Pages
- 4429-4438
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2074754374
- Cited by
- 314
- References
- 39
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.